OrphAI Therapeutics is dedicated to the identification and development of treatments for rare orphan conditions. Employing diverse methods, we actively seek promising assets to enhance our pipeline. Our ongoing clinical stage drug candidates are designed to address various orphan disorders, spanning amyotrophic lateral sclerosis, pulmonary hypertension, bronchiolitis obliterans post-lung transplant, pulmonary sarcoidosis, Ewin...
OrphAI Therapeutics is dedicated to the identification and development of treatments for rare orphan conditions. Employing diverse methods, we actively seek promising assets to enhance our pipeline. Our ongoing clinical stage drug candidates are designed to address various orphan disorders, spanning amyotrophic lateral sclerosis, pulmonary hypertension, bronchiolitis obliterans post-lung transplant, pulmonary sarcoidosis, Ewing Sarcoma, Rhabdoid Tumor, and SWI/SNF mutated or dysregulated cancers. Our commitment is to advance therapeutic solutions for these rare conditions with unmet medical needs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.